Fig. 6
Changes in immune subsets and HA receptors expression on tumor cells induced by ONCOFID-P-B™ treatment. Density (cells/mm2) of (a-f) immune cell populations and (g-l) tumor cells expressing each HA receptor at baseline, after the intensive phase (IP) and during or after the maintenance phase (MP) in responding and non-responding patients. Significantly different data are represented by *p < 0.05 and **p < 0.01. Floating box extends from 25th to 75th percentiles, line through the box indicates median, and bars extend from the smallest to largest values